237 related articles for article (PubMed ID: 18237197)
41. A novel CD44-binding peptide from the pro-matrix metalloproteinase-9 hemopexin domain impairs adhesion and migration of chronic lymphocytic leukemia (CLL) cells.
Ugarte-Berzal E; Bailón E; Amigo-Jiménez I; Albar JP; García-Marco JA; García-Pardo A
J Biol Chem; 2014 May; 289(22):15340-9. PubMed ID: 24739387
[TBL] [Abstract][Full Text] [Related]
42. Structure of human pro-matrix metalloproteinase-2: activation mechanism revealed.
Morgunova E; Tuuttila A; Bergmann U; Isupov M; Lindqvist Y; Schneider G; Tryggvason K
Science; 1999 Jun; 284(5420):1667-70. PubMed ID: 10356396
[TBL] [Abstract][Full Text] [Related]
43. Matrix metalloproteinase-2 and -9 activities in human keloids, hypertrophic and atrophic scars: a pilot study.
Tanriverdi-Akhisaroglu S; Menderes A; Oktay G
Cell Biochem Funct; 2009 Mar; 27(2):81-7. PubMed ID: 19165813
[TBL] [Abstract][Full Text] [Related]
44. The collagen binding domain of gelatinase A modulates degradation of collagen IV by gelatinase B.
Gioia M; Monaco S; Van Den Steen PE; Sbardella D; Grasso G; Marini S; Overall CM; Opdenakker G; Coletta M
J Mol Biol; 2009 Feb; 386(2):419-34. PubMed ID: 19109975
[TBL] [Abstract][Full Text] [Related]
45. Identification of amino acid residues of the matrix metalloproteinase-2 essential for its selective inhibition by beta-amyloid precursor protein-derived inhibitor.
Higashi S; Miyazaki K
J Biol Chem; 2008 Apr; 283(15):10068-78. PubMed ID: 18238779
[TBL] [Abstract][Full Text] [Related]
46. In situ localization and structural analysis of the malaria pigment hemozoin.
Frosch T; Koncarevic S; Zedler L; Schmitt M; Schenzel K; Becker K; Popp J
J Phys Chem B; 2007 Sep; 111(37):11047-56. PubMed ID: 17718555
[TBL] [Abstract][Full Text] [Related]
47. Melatonin decreases matrix metalloproteinase-9 activation and expression and attenuates reperfusion-induced hemorrhage following transient focal cerebral ischemia in rats.
Hung YC; Chen TY; Lee EJ; Chen WL; Huang SY; Lee WT; Lee MY; Chen HY; Wu TS
J Pineal Res; 2008 Nov; 45(4):459-67. PubMed ID: 18624955
[TBL] [Abstract][Full Text] [Related]
48. MMP-9 and -12 cause N-cadherin shedding and thereby beta-catenin signalling and vascular smooth muscle cell proliferation.
Dwivedi A; Slater SC; George SJ
Cardiovasc Res; 2009 Jan; 81(1):178-86. PubMed ID: 18852254
[TBL] [Abstract][Full Text] [Related]
49. The alpha 2 chain of collagen type VI sequesters latent proforms of matrix-metalloproteinases and modulates their activation and activity.
Freise C; Erben U; Muche M; Farndale R; Zeitz M; Somasundaram R; Ruehl M
Matrix Biol; 2009 Oct; 28(8):480-9. PubMed ID: 19698785
[TBL] [Abstract][Full Text] [Related]
50. MT1-MMP releases latent TGF-beta1 from endothelial cell extracellular matrix via proteolytic processing of LTBP-1.
Tatti O; Vehviläinen P; Lehti K; Keski-Oja J
Exp Cell Res; 2008 Aug; 314(13):2501-14. PubMed ID: 18602101
[TBL] [Abstract][Full Text] [Related]
51. Signatures of positive selection at hemopexin (PEX) domain of matrix metalloproteinase-9 (MMP-9) gene.
Liu Y; Zhao Y; Lu C; Fu M; Dou T; Tan X
J Biosci; 2015 Dec; 40(5):885-90. PubMed ID: 26648034
[TBL] [Abstract][Full Text] [Related]
52. Oligomerization through hemopexin and cytoplasmic domains regulates the activity and turnover of membrane-type 1 matrix metalloproteinase.
Lehti K; Lohi J; Juntunen MM; Pei D; Keski-Oja J
J Biol Chem; 2002 Mar; 277(10):8440-8. PubMed ID: 11779859
[TBL] [Abstract][Full Text] [Related]
53. Inhibition of MMP-3 or -9 suppresses lipopolysaccharide-induced expression of proinflammatory cytokines and iNOS in microglia.
Woo MS; Park JS; Choi IY; Kim WK; Kim HS
J Neurochem; 2008 Jul; 106(2):770-80. PubMed ID: 18419763
[TBL] [Abstract][Full Text] [Related]
54. Activation profiles of the zymogen of aspergilloglutamic peptidase.
Huang XP; Yabuki Y; Kojima M; Inoue H; Takahashi K
Biol Chem; 2007 Jan; 388(1):129-33. PubMed ID: 17214557
[TBL] [Abstract][Full Text] [Related]
55. Evidence of reciprocal reorientation of the catalytic and hemopexin-like domains of full-length MMP-12.
Bertini I; Calderone V; Fragai M; Jaiswal R; Luchinat C; Melikian M; Mylonas E; Svergun DI
J Am Chem Soc; 2008 Jun; 130(22):7011-21. PubMed ID: 18465858
[TBL] [Abstract][Full Text] [Related]
56. The hemopexin-like domain (C domain) of human gelatinase A (matrix metalloproteinase-2) requires Ca2+ for fibronectin and heparin binding. Binding properties of recombinant gelatinase A C domain to extracellular matrix and basement membrane components.
Wallon UM; Overall CM
J Biol Chem; 1997 Mar; 272(11):7473-81. PubMed ID: 9054449
[TBL] [Abstract][Full Text] [Related]
57. Structural requirements for bone sialoprotein binding and modulation of matrix metalloproteinase-2.
Jain A; Karadag A; Fisher LW; Fedarko NS
Biochemistry; 2008 Sep; 47(38):10162-70. PubMed ID: 18729384
[TBL] [Abstract][Full Text] [Related]
58. Alteration of substrate specificity of rat neurolysin from matrix metalloproteinase-2/9-type to -3-type specificity by comprehensive mutation.
Kadonosono T; Kato-Murai M; Ueda M
Protein Eng Des Sel; 2008 Aug; 21(8):507-13. PubMed ID: 18499680
[TBL] [Abstract][Full Text] [Related]
59. Structural analysis of the alpha(2) integrin I domain/procollagenase-1 (matrix metalloproteinase-1) interaction.
Stricker TP; Dumin JA; Dickeson SK; Chung L; Nagase H; Parks WC; Santoro SA
J Biol Chem; 2001 Aug; 276(31):29375-81. PubMed ID: 11359774
[TBL] [Abstract][Full Text] [Related]
60. A physiochemical mechanism of hemozoin (beta-hematin) synthesis by malaria parasite.
Tripathi AK; Garg SK; Tekwani BL
Biochem Biophys Res Commun; 2002 Jan; 290(1):595-601. PubMed ID: 11779214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
